UK markets open in 4 hours 19 minutes
NIKKEI 225
37,806.43 +177.95 (+0.47%) HANG SENG
17,555.57 +271.03 (+1.57%) CRUDE OIL
83.81 +0.24 (+0.29%) GOLD FUTURES
2,345.80 +3.30 (+0.14%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,530.52 +202.52 (+0.39%)
OPKO Health, Inc. (OPK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.2300 |
| Open | 1.2000 |
| Bid | 1.1800 x 2000 |
| Ask | 1.2700 x 2000 |
| Day's range | 1.1900 - 1.2300 |
| 52-week range | 0.8500 - 2.2400 |
| Volume | |
| Avg. volume | 9,026,346 |
| Market cap | 850.33M |
| Beta (5Y monthly) | 1.84 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2500 |
| Earnings date | 01 May 2024 - 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.25 |
ZacksOPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
OPKO Health (OPK) expects to re-establish profitability in its clinical laboratory business via its latest efforts to streamline its laboratory services business.
- Zacks
Labcorp (LH) to Boost Clinical Diagnostics With New Deal
The recent deal will augment Labcorp's (LH) laboratory services network and expand access to the company's high-quality clinical laboratory services.
PR NewswireLabcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health.
© 2024 Yahoo. All rights reserved.